Literature DB >> 1618472

Biglycan and decorin gene expression in normal and fibrotic rat liver: cellular localization and regulatory factors.

D H Meyer1, N Krull, K L Dreher, A M Gressner.   

Abstract

The expression of genes encoding the core proteins of the novel small chondroitin/dermatan sulfate proteoglycans decorin and biglycan was studied in the livers of normal rats and in liver tissue during fibrogenesis induced by prolonged bile-duct ligation and thioacetamide poisoning. The cell types responsible for the expression of these transcripts and some key regulatory factors were identified. Both biglycan and decorin messenger RNAs were detected in normal liver tissue. Their relative abundance increased strongly during liver fibrogenesis, reaching highest levels in cirrhotic tissue 8 wk after common bile-duct ligation and after 12 wk of peroral thioacetamide administration, respectively. Specific proteoglycan transcripts were almost absent in hepatocytes from normal and regenerating liver, and only trace amounts were observed in freshly isolated and cultured Kupffer cells. Fat-storing cells clearly expressed both biglycan and decorin transcripts. The steady-state levels of their messenger RNAs increased threefold (biglycan) and fourfold (decorin) during primary culture. Myofibroblastlike cells (transformed fat-storing cells after the second passage) contained dramatically reduced levels of decorin messenger RNA and also lower levels of biglycan messenger RNA compared with primary cultures. These changes of core protein messenger RNA expression were not reflected by the synthesis rates of medium proteoglycans labeled with 35S as Na2SO4, in particular that of medium chondroitin sulfate. Transiently acidified (but not native) conditioned media from Kupffer cells and myofibroblastlike cells and transforming growth factor-beta 1 enhanced the relative abundances of biglycan and decorin messenger RNAs up to five times in primary-cultured fat-storing cells. Biglycan and decorin in myofibroblastlike cells did not respond to these stimuli.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618472     DOI: 10.1002/hep.1840160131

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

1.  The importance of serum biglycan levels as a fibrosis marker in patients with chronic hepatitis B.

Authors:  Rafiye Ciftciler; Seren Ozenirler; Aysegul Atak Yucel; Mustafa Cengiz; Gulbanu Erkan; Erkan Buyukdemirci; Cemile Sönmez; Guldal Yılmaz Esendaglı
Journal:  J Clin Lab Anal       Date:  2016-12-07       Impact factor: 2.352

2.  Versican: a novel modulator of hepatic fibrosis.

Authors:  Terence N Bukong; Sean B Maurice; Barinder Chahal; David F Schaeffer; Paul J Winwood
Journal:  Lab Invest       Date:  2016-01-11       Impact factor: 5.662

Review 3.  Proteoglycans in liver cancer.

Authors:  Kornélia Baghy; Péter Tátrai; Eszter Regős; Ilona Kovalszky
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

4.  Expression of extracellular matrix proteoglycans perlecan and decorin in carbon-tetrachloride-injured rat liver and in isolated liver cells.

Authors:  M Gallai; I Kovalszky; T Knittel; K Neubauer; T Armbrust; G Ramadori
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

Review 5.  Small proteoglycans.

Authors:  H Kresse; H Hausser; E Schönherr
Journal:  Experientia       Date:  1993-05-15

6.  Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis.

Authors:  Tamara N Pereira; Meagan J Walsh; Peter J Lewindon; Grant A Ramm
Journal:  World J Gastrointest Pathophysiol       Date:  2010-06-15

7.  Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis.

Authors:  Xuelian Xiong; Henry Kuang; Sahar Ansari; Tongyu Liu; Jianke Gong; Shuai Wang; Xu-Yun Zhao; Yewei Ji; Chuan Li; Liang Guo; Linkang Zhou; Zhimin Chen; Paola Leon-Mimila; Meng Ting Chung; Katsuo Kurabayashi; Judy Opp; Francisco Campos-Pérez; Hugo Villamil-Ramírez; Samuel Canizales-Quinteros; Robert Lyons; Carey N Lumeng; Beiyan Zhou; Ling Qi; Adriana Huertas-Vazquez; Aldons J Lusis; X Z Shawn Xu; Siming Li; Yonghao Yu; Jun Z Li; Jiandie D Lin
Journal:  Mol Cell       Date:  2019-08-08       Impact factor: 17.970

8.  Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycaemia.

Authors:  N A Wahab; K Harper; R M Mason
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

9.  Increased expression of chondroitin sulphate proteoglycans in rat hepatocellular carcinoma tissues.

Authors:  Xiao-Li Jia; Si-Yuan Li; Shuang-Suo Dang; Yan-An Cheng; Xin Zhang; Wen-Jun Wang; Clare E Hughes; Bruce Caterson
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

10.  Source of peritoneal proteoglycans. Human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycans.

Authors:  S Yung; G J Thomas; E Stylianou; J D Williams; G A Coles; M Davies
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.